Pre-market Movers: SAI, OLMA, SHFS, AMV, VLD…

us pre market 053119 30sep22 lt

The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.15 A.M. ET).

In the Green

SAI.TECH Global Corporation (SAI) is up over 47% at $3.33
Olema Pharmaceuticals, Inc. (OLMA) is up over 21% at $3.30
SHF Holdings Inc (SHFS) is up over 20% at $10.57
Atlis Motor Vehicles Inc (AMV) is up over 17% at $40.04
Velo3D, Inc. (VLD) is up over 13% at $4.65
Getty Images Holdings, Inc. (GETY) is up over 10% at $7.80
Honda Motor Co., Ltd. (HMC) is up over 8% at $23.97
Scienjoy Holding Corporation (SJ) is up over 8% at $2.44
IonQ, Inc. (IONQ) is up over 6% at $5.09
KE Holdings Inc. (BEKE) is up over 5% at $17.18
Crescent Point Energy Corp. (CPG) is up over 5% at $6.49
Fortuna Silver Mines Inc. (FSM) is up over 5% at $2.52

In the Red

Rent-A-Center, Inc. (RCII) is down over 12% at $19.59
NIKE, Inc. (NKE) is down over 10% at $85.43
Motus GI Holdings, Inc. (MOTS) is down over 9% at $2.32
TH International Ltd (THCH) is down over 8% at $6.70
Vertical Aerospace Ltd. (EVTL) is down over 6% at $8.99
Alpine Summit Energy Partners Inc (ALPS) is down over 5% at $4.99

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
Follow RTT